Filings

ASX Filings

Date	Description
January 3, 2022	Opthea Appoints Chief Commercial Officer to Lead Commercialization of OPT-302 for Wet AMD
December 23, 2021	Ceasing to be a substantial holder
December 16, 2021	Becoming a substantial holder
December 14, 2021	Cleansing Notice
December 14, 2021	Ceasing to be a substantial holder

There are no SEC filings available.

Data provided by Kaleidoscope.